Prevention of Invasive Cronobacter Infections in Young Infants Fed Powdered Infant Formulas
Author:
- 1 November 2012
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 130 (5) , e1076-e1084
Abstract
BACKGROUND: Invasive Cronobacter infection is rare, devastating, and epidemiologically/microbiologically linked to powdered infant formulas (PIFs). In 2002–2004, the US Food and Drug Administration advised health care professionals to minimize PIF and powdered human milk fortifier (HMF)’s preparation, feeding, and storage times and avoid feeding them to hospitalized premature or immunocompromised neonates. Labels for PIF used at home imply PIF is safe for healthy, term infants if label instructions are followed. METHODS: 1) Medical, public health, Centers for Disease Control and Prevention, US Food and Drug Administration, and World Health Organization records, publications, and personal communications were used to compare 68 (1958–2003) and 30 (2004–2010) cases of invasive Cronobacter disease in children without underlying disorders. 2) The costs of PIFs and ready-to-feed formulas (RTFs) were compared. RESULTS: Ninety-nine percent (95/96) of all infected infants were <2 months old. In 2004–2010, 59% (17/29) were term, versus 24% (15/63) in 1958–2003; 52% (15/29) became symptomatic at home, versus 21% (13/61). Of all infected infants, 26% (22/83) had received breast milk (BM), 23% (19/82) RTF, and 90% (76/84) PIF or HMF. Eight percent received BM and not PIF/HMF; 5%, RTF without PIF/HMF. For at least 10 PIF-fed infants, label instructions were reportedly followed. Twenty-four ounces of milk-based RTF cost $0.84 more than milk-based PIF; 24 ounces of soy-based RTF cost $0.24 less than soy-based PIF. CONCLUSIONS: Cronobacter can infect healthy, term (not just hospitalized preterm) young infants. Invasive Cronobacter infection is extremely unusual in infants not fed PIF/HMF. RTFs are commercially sterile, require minimal preparation, and are competitively priced. The exclusive use of BM and/or RTF for infants <2 months old should be encouraged.Keywords
This publication has 32 references indexed in Scilit:
- Prevalence of Cronobacter spp. in a powdered infant formula processing environmentInternational Journal of Food Microbiology, 2010
- Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein ALaboratory Investigation, 2009
- Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov.International Journal of Systematic and Evolutionary Microbiology, 2008
- Genotypic and Phenotypic Analysis of Enterobacter sakazakii Strains from an Outbreak Resulting in Fatalities in a Neonatal Intensive Care Unit in FranceJournal of Clinical Microbiology, 2007
- Enterobacter sakazakii in food and beverages (other than infant formula and milk powder)International Journal of Food Microbiology, 2007
- InvasiveEnterobacter sakazakiiDisease in InfantsEmerging Infectious Diseases, 2006
- Enterobacter sakazakii: An Emerging Pathogen in Powdered Infant FormulaClinical Infectious Diseases, 2006
- Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula milk and related productsFood Microbiology, 2004
- Outbreak of Necrotizing Enterocolitis Associated with Enterobacter sakazakii in Powdered Milk FormulaJournal of Clinical Microbiology, 2001
- NEONATAL DEATH FROM PIGMENTED COLIFORM INFECTIONThe Lancet, 1961